Perrigo Sued By Galderma for Patent Infringement over Clobex

Perrigo, an Israel based generic pharmaceutical company has filed an Abbreviated New Drug Application (ANDA) Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for clobetasol propionate shampoo, 0.05%.

In response, on August 17, 2010, Galderma, the listed patent owner for the product, which is commercialized as Clobex, have filed suit alleging patent infringement in the United States District Court for the Northern District of Texas to prevent Perrigo from proceeding with the commercialization of this product.

The product is substitutable to Galderma’s Shampoo, 0.05%, a topical corticosteroid indicated for the treatment of moderate to severe psoriasis of the scalp. Sales for the brand exceed $5o million a year.



Categories: drugs, infringement, Intellectual Property, Israel, pharmaceuticals, pharmaceuticals and Biotechnology

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: